With over 55 million people living with dementia worldwide and numbers expected to increase to 139 million by 2050, there has never been a more vital time for ADI and WW-FINGERS to work together in raising awareness, sharing knowledge and building capacity to better promote dementia risk reduction. Both ADI and WW-FINGERS will work together to increase impact and help improve the lives of people affected by dementia.
The WW-FINGERS Scientific Helpdesk at the FINGERS Brain Health Institute supports the network members for clinical trials harmonization and optimization, implementation of a federated data system, and joint data analysis.
The WW-FINGERS Scientific Helpdesk also supports the network expansion, with a focus on low- and middle-income countries, where a more rapid growth of dementia cases is expected in coming years.bit.ly/3JB2AqUwor
Equally, we hope to increase opportunities for collaboration by dovetailing some of our work around non-communicable diseases (NCDs) into reinforcing the importance of addressing the public health crisis that dementia presents, leveraging the risk reduction success of WW-FINGERS for all NCDs.
Paola Barbarino, ADI CEO said: “We are delighted to join forces with WW-FINGERS to promote tangible risk reduction interventions and to forge greater links with our ADI members, particularly in low- and middle-income countries. This is an exciting opportunity to raise awareness and to encourage governments to include strong risk reduction strategies in their national dementia plans.”
Professor Miia Kivipelto, Founder and Scientific leader of the WW-FINGERS network said:“We are so happy for the growing collaboration with ADI. The partnership between ADI and WW-FINGERS will be pivotal in making dementia prevention a truly global effort, and for the development of preventive interventions which are effective and feasible for different populations.”
